How can we predict behavior of nanoparticles in vivo?

Nanomedicine (Lond). 2016 Feb;11(3):189-92. doi: 10.2217/nnm.15.192. Epub 2016 Jan 19.

Authors

Boris Polyak¹, Bernardo Cordovez²

Affiliations

¹ Laboratory of Magnetic Drug Targeting, Department of Surgery & Department of Pharmacology & Physiology, Drexel University, College of Medicine, Philadelphia, PA 19102, USA.
² Co-founder & President, Optofluidics, Inc., Philadelphia, PA 19104, USA.

PMID: 26783731
DOI: 10.2217/nnm.15.192

No abstract available

Keywords: nanomedicine; nanoparticle biological identity; nanoparticles; protein corona; structure-activity models.

Publication types

Editorial
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Animals
Humans
Nanoparticles*

Grants and funding

R01HL107771/HL/NHLBI NIH HHS/United States